This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Müller, G.
Right arrow Articles by Frick, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Müller, G.
Right arrow Articles by Frick, W.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, July 2001, p. 4553-4567, Vol. 21, No. 14
0270-7306/01/$04.00+0   DOI: 10.1128/MCB.21.14.4553-4567.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.

Redistribution of Glycolipid Raft Domain Components Induces Insulin-Mimetic Signaling in Rat Adipocytes

Günter Müller,* Christian Jung, Susanne Wied, Stefan Welte, Holger Jordan, and Wendelin Frick

Aventis Pharma Germany, 65926 Frankfurt am Main, Germany

Received 8 November 2000/Returned for modification 8 February 2001/Accepted 15 April 2001


    ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Caveolae and caveolin-containing detergent-insoluble glycolipid-enriched rafts (DIG) have been implicated to function as plasma membrane microcompartments or domains for the preassembly of signaling complexes, keeping them in the basal inactive state. So far, only limited in vivo evidence is available for the regulation of the interaction between caveolae-DIG and signaling components in response to extracellular stimuli. Here, we demonstrate that in isolated rat adipocytes, synthetic intracellular caveolin binding domain (CBD) peptide derived from caveolin-associated pp59Lyn (10 to 100 µM) or exogenous phosphoinositolglycan derived from glycosyl-phosphatidylinositol (GPI) membrane protein anchor (PIG; 1 to 10 µM) triggers the concentration-dependent release of caveolar components and the GPI-anchored protein Gce1, as well as the nonreceptor tyrosine kinases pp59Lyn and pp125Fak, from interaction with caveolin (up to 45 to 85%). This dissociation, which parallels redistribution of the components from DIG to non-DIG areas of the adipocyte plasma membrane (up to 30 to 75%), is accompanied by tyrosine phosphorylation and activation of pp59Lyn and pp125Fak (up to 8- and 11-fold) but not of the insulin receptor. This correlates well to increased tyrosine phosphorylation of caveolin and the insulin receptor substrate protein 1 (up to 6- and 15-fold), as well as elevated phosphatidylinositol-3' kinase activity and glucose transport (to up to 7- and 13-fold). Insulin-mimetic signaling by both CBD peptide and PIG as well as redistribution induced by CBD peptide, but not by PIG, was blocked by synthetic intracellular caveolin scaffolding domain (CSD) peptide. These data suggest that in adipocytes a subset of signaling components is concentrated at caveolae-DIG via the interaction between their CBD and the CSD of caveolin. These inhibitory interactions are relieved by PIG. Thus, caveolae-DIG may operate as signalosomes for insulin-independent positive cross talk to metabolic insulin signaling downstream of the insulin receptor based on redistribution and accompanying activation of nonreceptor tyrosine kinases.


    INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Caveolae, caveolin-containing small invaginations of the plasma membrane expressed in many differentiated cells (2, 50, 51, 54), and their biochemical correlate, detergent-insoluble glycolipid-enriched raft domains (DIG) (5, 53), harbor a number of components of various intracellular signal transduction pathways, including G protein-coupled receptors, heterotrimeric and small G proteins, nonreceptor tyrosine kinases (NRTK), components of the Ras/mitogen-activated protein kinase (MAPK) pathway, protein kinase C isoforms, endothelial nitric oxide synthase (eNOS), and glycosyl-phosphatidylinositol-anchored plasma membrane proteins (GPI proteins; 2, 55, 58, 59, 60). As a consequence, these structures may function as sites for direct physical interaction of signaling components where (positive or negative) cross talk between the corresponding signaling pathways takes place (49). A large body of evidence strongly suggests that caveolin family members (caveolins 1, 2, and 3 and flotillins) (3, 21) operate as scaffolding proteins which organize and concentrate cholesterol and glycosphingolipids as well as lipid-modified signaling proteins within caveolae-DIG, thereby suppressing their activity via direct interaction with caveolin (31, 32, 61). Recently, it was demonstrated that caveolin 1 functionally suppresses the GTPase activity of heterotrimeric G proteins and blocks the activity of eNOS as well as (receptor and nonreceptor) tyrosine kinases by direct binding of a common domain within the caveolins, the caveolin scaffolding domain (CSD) to the corresponding caveolin binding domain (CBD) of the signaling protein (10, 27, 48). Functional CBDs have also been identified in serine/threonine kinases (51), where they are located within the conserved kinase subdomain IX. Taken together, this argues for caveolin operating as a general kinase inhibitor (11). Compatible with this hypothesis is the finding that synthetic CSD peptide (CSDP) inhibits Src family tyrosine kinases (c-Src/Fyn), epidermal growth factor receptor, MAPK, G protein-coupled receptor kinases, and protein kinases C and A, with similar potencies in vitro (7, 11, 14, 31, 48, 51). However, in contrast to the large body of in vitro evidence for the so-called caveola signaling hypothesis (34), there is only limited demonstration for functional relevance of the CBD-CSD interaction in vivo. Inactivation of the CBD of eNOS by site-directed mutagenesis (within the FSAAPFSGW motif; italics indicate invariant amino acids of the CBD consensus sequence) (see Fig. 1) led to the blockade of the ability of caveolin 1 to inhibit eNOS activity, thus indicating functional relevance of caveolin binding to a signaling protein in vivo (20).

If relevant in vivo, the inhibitory interaction between caveolin and signaling molecules should be accessible for modulation in response to extracellular and intracellular signals. Activation of signaling pathways engaging CBD-harboring components requires their relief from binding to or inhibition by caveolin. The molecular mechanism for long-term response may be based on the regulation of caveolin gene expression. Consistent with this hypothesis, caveolin 1 mRNA and protein expression as well as the number of caveolae are dramatically diminished upon cell transformation by activated oncogenes, such as H-Ras (28). In these transformed cells, ectopic caveolin 1 expression and concomitant formation of caveolae prevented the transformed phenotype, accompanied by downregulation of the MAPK pathway (15). Conversely, antisense-mediated reduction in caveolin 1, but not caveolin 2, expression in NIH 3T3 cells led to oncogenic transformation and constitutive activation of the MAPK cascade (19). Interestingly, caveolins 1 and 2 are coexpressed and form heterooligomeric DIG via their membrane-spanning domains in most cell types (12, 56). Thus, in addition to the absolute caveolin 1 level, the stoichiometry of caveolins 1 and 2 protein expression could affect the inhibitory potency by the masking of CSD of caveolin 1 by CSD of caveolin 2 within the assembled heterooligomeric caveolae-DIG.

Here, we demonstrate that in isolated rat adipocytes, two NRTK are downregulated by localization in DIG and by binding to caveolin and upregulated by release from DIG and by dissocation from caveolin in response to phosphoinositolglycans (PIG), cleavage products of GPI protein anchors (18, 26, 41). Short-term redistribution of these NRTKs from caveolae-DIG induces potent insulin-independent activation of metabolic insulin signaling.


    MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Materials. Radiochemicals and chemiluminescent reagents (Renaissance Chemiluminescence Detection System) were bought from NEN/DuPont (Bad Homburg, Germany); PIG 41, 37, 7, and 1 (18) were made available by Jochen Bauer and Andrea Bauer (Department of Medicinal Chemistry of Aventis Pharma, Frankfurt am Main, Germany); and antibodies were obtained as follows. For immunoprecipitation, antibodies against pp59Lyn (clone 42), pp125Fak (clone 77), and caveolin 1 (rabbit) were from Transduction Laboratories (Lexington, Ky.); antibodies against total human recombinant (insect cells; purified by gel filtration) insulin receptor substrate protein 1 (IRS-1) and IRS-2 (rabbit) were from Biotrend (Cologne, Germany); and antibodies against human insulin receptor beta -subunit (IRbeta ; monoclonal) were from Upstate Biotechnology (Lake Placid, N.Y.). For immunoblotting, antibodies against phosphotyrosine (clone PY20) were from Transduction Laboratories; those against phosphotyrosine (clone 4G10) were from Upstate Biotechnology; those against synthetic peptide corresponding to the carboxy-terminal sequence comprising amino acids 1223 to 1235 of rat IRS-1 (rabbit) were from Suzanne Dalle (Humbold University, Berlin, Germany); antibodies against paxillin (clone 165), caveolin (rabbit), pp59Lyn (clone 32), and pp125Fak (clone 197) were from Transduction Laboratories; those against human integrin beta 1 and IRbeta were from Upstate Biotechnology; and those against rat glucose transporter isoform 1 (Glut1) and Glut4 (rabbit) were from Biotrend. Rabbit muscle enolase, 1-methyl-2-phenylethyladenosine, fatty-acid-free bovine serum albumin (BSA; fraction V) and N-ethylmaleimide were purchased from Sigma (Deisenhofen, Germany); protein A- and G-Sepharose were delivered by Pharmacia/Upjohn (Freiburg, Germany); proteinase inhibitors and adenosine deaminase were from Roche Molecular Biochemicals (Mannheim, Germany); precast gels were purchased from Novex (San Diego, Calif.); and polyvinylidene difluoride membranes were obtained from Millipore, Eschborn, Germany.

Synthesis of peptides. The wild-type and mutant CBD peptides (CBDP) derived from pp59Lyn as well as CSDP (Fig. 1) were synthesized on an Applied Biosystems Model 431A Peptide Sequencer by using 9-fluorenylmethoxy carbonyl as the alpha -amino protecting group. Coupling of amino acids to the nascent peptide was carried out in N-methylpyrrolidone using HOBT-HBTU [N-hydroxybenzotriazole-2-(1H-benzotriazole-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate]. 9-Fluorenylmethoxy carbonyl was removed by treatment of the peptide with 15% piperidine in N-methylpyrrolidone. Cleavage of the peptide from the resin and deprotection of amino acid chains was carried out by reaction with 95% trifluoroacetic acid (3 h, room temperature) in water containing phenol, ethanedithiol, and thioanisole as scavengers. Peptide was removed from resin by filtration and precipitated in diethyl ether. Peptides were purified by reversed-phase high-performance liquid chromatography, and their molecular weights were confirmed by mass spectroscopy.


View larger version (27K):
[in this window]
[in a new window]
 
FIG. 1.   Structural and functional organization of caveolin 1alpha and the amino acid sequences of the wild-type or mutant CSDP derived from caveolin 1alpha , 2, and 3 as well as CBDP derived from pp59Lyn. The CBD consensus sequence for functional interaction of signaling proteins with caveolin is also given. Palmitoylation at the carboxy-terminal domain of caveolin 1alpha is thought to support caveolar assembly (56, 60).

Preparation of rat adipocytes and incubation with PIG. Adipocytes were isolated by collagenase digestion from epididymal fat pads of male Wistar rats (140 to 160 g, fed ad libitum) as described previously (40). At a final concentration of 100 µl of packed cell volume per ml (determined by aspiration of small aliquots into capillary hematocrit tubes and centrifugation for 90 s in a microhematocrit centrifuge in order to measure the fractional occupation of the suspension by the adipocytes; 10% cytocrit corresponds to about 1.5 × 106 cells/ml), cells were incubated in HEPES-based Krebs-Ringer solution (KRH; 0.12 M NaCl, 4.7 mM KCl, 2.5 mM CaCl2, 1.2 mM MgSO4, 1.2 mM KH2PO4, 20 mM HEPES-KOH, pH 7.4) containing 2% (wt/vol) BSA, 100 µg of gentamicin/ml, 100 nM 1-methyl-2-phenylethyladenosine, 0.5 U of adenosine deaminase/ml, 0.5 mM sodium pyruvate, and 5 mM D-glucose in the presence of PIG (dissolved in 20 mM HEPES-KOH, pH 7.4) at 37°C in a shaking water bath with constant bubbling with 5% CO2-95% O2 for the periods indicated.

Electroporation of isolated rat adipocytes Electroporation was performed as described previously (44) by incubating (at 25°C) the adipocytes (25% cytocrit) in a cuvette in 0.8 ml of 4.74 mM NaCl, 118 mM KCl, 0.38 mM CaCl2, 1 mM EGTA, 1.19 mM MgSO4, 1.19 mM KH2PO4, 25 mg of BSA/ml, 3 mM sodium pyruvate, and 25 mM HEPES-KOH (pH 7.4) in the presence of CBDP-CSDP (dissolved in dimethyl sulfoxide at 30 mM; final dimethyl sulfoxide concentration of 1%, which was also contained in control incubations and did not affect adipocyte viability) at the concentrations indicated and using a Gene Pulser Transfection Apparatus (Bio-Rad, Munich, Germany; set at a capacitance of 25 µF and voltage of 2 kV/cm) for six shocks. The cells from five electroporations were pooled and centrifuged (200 × g, 1 min, swing-out rotor). After aspiration of the infranatant, the cells were washed once with 40 ml of the above buffer containing 4% BSA, suspended in 20 ml of Dulbecco's minimal essential medium containing 5 mM glucose, 0.5 M mM sodium pyruvate, 4 mM L-glutamine, 200 nM 1-methyl-2-phenylethyladenosine, 100 µg of gentamicin/ml, 1% BSA, and 25 mM HEPES-KOH (pH 7.4), and then incubated (1 h, 37°C) under 5% CO2-95% O2 prior to stimulation with PIG.

Preparation of total-cell lysate and plasma membranes. After stimulation and/or electroporation, rat adipocytes (5 × 107 cells) were washed once with KRH containing 0.25 M sucrose and 2 mM sodium pyruvate by flotation (200 × g, 2 min) and aspiration of the infranatant and were immediately homogenized in 10 ml of lysis buffer (25 mM Tris-HCl, pH 7.4, 0.5 mM EDTA, 0.25 mM EGTA, 0.25 M sucrose, 50 mM NaF, 5 mM sodium pyrophosphate, 25 mM glycerol-3-phosphate, and 1 mM sodium orthovanadate, supplemented with protease inhibitors [10 µg of leupeptin/ml, 2 µM pepstatin, 10 µg of aprotinin/ml, 5 µM antipain, 5 mM iodoacetate, 100 µM phenylmethylsulfonyl fluoride, 4 mM benzamidine]) by using a motor-driven Teflon-in-glass homogenizer (10 strokes with a loosely fitting pestle) at 22°C. The following procedures were performed at 4°C (43). After centrifugation (1,500 × g, 5 min), the postnuclear infranatant was separated from the fat cake, and the pellet fraction (containing adipocyte ghosts and cell debris) was removed by suction with a needle. For preparation of plasma membranes, the postnuclear infranatant was centrifuged (12,000 × g, 15 min). The pellet was suspended in 10 ml of homogenization buffer and recentrifuged (1,000 × g, 10 min). The supernatant was centrifuged (12,000 × g, 20 min). The washed pellet was suspended in 1 ml of homogenization buffer, layered onto a 5-ml cushion of 38% (wt/vol) sucrose, 25 mM Tris-HCl (pH 7.4), and 1 mM EDTA, and centrifuged (110,000 × g, 1 h). The membranes at the interface between the two layers (0.5 ml) were removed by suction, diluted with four volumes of homogenization buffer, and layered on top of an 8-ml cushion of 28% Percoll, 0.25 M sucrose, 1 mM EDTA, and 25 mM Tris-HCl (pH 7.0). After centrifugation (45,000 × g, 30 min), the plasma membranes were withdrawn from the lower third of the gradient (0.5 ml) with a Pasteur pipette, diluted with 10 volumes of homogenization buffer, and centrifuged (200,000 × g, 90 min). The washed pellet was suspended in the same buffer at 0.5 mg of protein/ml. For solubilization of plasma membranes and preparation of total-cell lysate, plasma membranes and postnuclear infranatant, respectively, were supplemented with deoxycholate and Nonidet P-40 (final concentrations, 0.3 and 0.2%, respectively), and after incubation (1 h, 4°C), the solubilized plasma membranes and total-cell lysates were cleared from insoluble material by centrifugation (100,000 × g, 1 h, 4°C) and used for photoaffinity labeling and (co)immunoprecipitation.

Preparation of DIG. (i) Detergent method. Washed adipocytes (3.5 × 106) were suspended in 1.5 ml of lysis buffer (25 mM morpholinoethanesulfonic acid [MES], pH 6.0, 150 mM NaCl, 5 mM EDTA, 1% Triton X-100, 0.2 mM sodium orthovanadate, and protease inhibitors) and incubated for 20 min on ice. The cells were lysed with 10 strokes in a manual Teflon-in-glass homogenizer over the course of 1 h at 4°C. The lysate was centrifuged (1,300 × g, 5 min) to pellet unbroken cells, cellular debris, nuclei, and large insoluble material. A 1-ml volume of the postnuclear supernatant was subjected to sucrose gradient centrifugation by mixing with an equal volume of 85% sucrose, 25 mM MES (pH 6.0), 150 mM NaCl, and 5 mM EDTA at the bottom of a 12-ml centrifuge tube which was overlaid with 5.5 ml of 35% sucrose and then 3.5 ml of 5% sucrose in the same medium. After centrifugation (230,000 × g, Beckman SW41 rotor, 18 h, 4°C), 0.9-ml fractions were collected from top to bottom and termed fractions 1, 2, 3, etc. The bottom fraction was fraction 12. Fraction 5 appeared as a white, light-scattering band under illumination located at 5 to 7% sucrose at the 35% sucrose interface. DIG contained in fraction 5 were pelleted by dilution of the sucrose with 5 volumes of 50 mM HEPES-KOH containing protease inhibitors and centrifugation (200,000 × g, 2 h).

(ii) Carbonate method. Plasma membranes (200 µg) were pelleted (200,000 × g, 90 min), suspended in 1.5 ml of 0.5 M Na2CO3 (pH 11) containing protease inhibitors, and sonicated (three 30-s bursts with 1-min intervals on ice; Branson B-12, power stage 4). The suspension was then adjusted to 45% sucrose in a medium containing 15 mM MES-KOH (pH 6.5), 75 mM NaCl, and 0.25 M Na2CO3 overlaid with 2 ml each of 35, 25, 15, and 5% sucrose in the same medium and was centrifuged (230,000 × g, Beckman SW41 rotor, 18 h). The light-scattering band of flocculent material just below the 15 to 25% sucrose interface was collected as DIG using a 19-gauge needle and a syringe (about 1.5 ml). Alternatively, washed adipocytes (0.5 × 107 cells) were suspended in 2 ml of sodium carbonate buffer and homogenized sequentially using a loosely fitting Dounce homogenizer (10 strokes) and a sonicator (three 20-s bursts). The homogenate (2 ml) was then adjusted to 45% sucrose by addition of 2 ml of 90% sucrose, 50 mM MES-KOH (pH 6.5), and 150 mM NaCl (final pH of the mixture, 10.2). A discontinuous sucrose gradient was formed by overlaying this solution with 4 ml of 35% sucrose and 4 ml of 5% sucrose, both in the same buffer containing 0.25 M Na2CO3. After centrifugation (see above), 0.85-ml gradient fractions were collected to yield a total of 14 fractions. The individual gradient fractions were pooled into DIG (fractions 4 to 7) and non-DIG areas (fractions 10 to 14). The membranes from each of the pooled gradient fractions obtained by either method were diluted two- to threefold with 25 mM MES (pH 6.5), 150 mM NaCl, and 1% Triton X-100, collected by centrifugation (50,000 × g, 30 min, 4°C), resuspended in nondissociating buffer (10 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1% Nonidet P-40, 5 mM EDTA, 0.5 mM EGTA, 1 mM sodium orthovanadate, 50 mM NaF, and protease inhibitors) or dissociating buffer (composed of nondissociating buffer supplemented with 60 mM beta -octylthioglucoside, 0.3% deoxycholate) as indicated, incubated (1 h, on ice), and used for (co)immunoprecipitation, immunoblotting, or photoaffinity labeling.

Immune complex kinase assays Immune complex kinase assays were performed as described previously (17, 44) with minor modifications. Briefly, pp59Lyn or pp125Fak immune complexes were suspended in 30 µl of kinase buffer (50 mM HEPES-KOH, pH 7.4, 100 mM NaCl, 1.25 mM MnCl2, 12.5 mM MgCl2, 1.25 mM EGTA, 0.5 mM dithiothreitol, 1 mM Na3VO4) containing [gamma -32P]ATP (final concentrations: pp59Lyn, 40 µM, 0.2 mCi/ml; pp125Fak, 100 µM, 0.5 mCi/ml) or 1 mM ATP and were incubated (pp59Lyn, 15 min; pp125Fak, 3 min; 22°C) in the presence of 1 µg of heat-denatured enolase. Phosphorylation was terminated by addition of 10 µl of fourfold-concentrated Laemmli buffer and boiling. The phosphoproteins were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (10% Bis-Tris resolving gel, morpholinopropanesulfonic acid [MOPS]-SDS running buffer) and analyzed for phosphotyrosine by phosphorimaging ([gamma -32P]ATP) or immunoblotting (ATP). Under these conditions, the kinase reactions were linear with time for the assay period.

Miscellaneous Phosphatidylinositol 3'-kinase (PI-3'K) assay, photoaffinity labeling of Gce1 with 8-N3-[32P]cyclic AMP (cAMP), immunoprecipitation, and immunoblotting were performed as described previously (17, 39, 43, 44). Protein concentration was determined using the bicinchoninic acid protein determination kit from Pierce (Rockford, Ill.) and BSA as a calibration standard. Autoradiographs and direct photoimages were processed and quantified by computer-assisted video densitometry using the Storm 860 PhosphorImager system (Molecular Dynamics, Gelsenkirchen, Germany). Figures of autoradiographs and photoimages were constructed using the Adobe Photoshop software (Adobe Systems Inc., Mountain View, Calif.). The recovery in the amount of immunoprecipitated protein was corrected (by fold increase or percent stimulation) for the amount of protein actually applied onto the gel as revealed by homologous immunoblotting. Each experiment and incubation was performed with different batches of adipocytes (see figure legends), with two to four independent immunoprecipitation, kinase assay, immunoblotting, or photoaffinity labeling analyses.


    RESULTS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Characterization of DIG in rat adipocytes. DIG are assumed to represent the biochemical correlate for (certain subsets of) the morphologically defined caveolae and/or precaveolae prior to their invagination or budding from the plasma membrane (49, 60). The protein composition of DIG and non-DIG areas prepared by the carbonate method from purified plasma membranes or by the detergent method from total-cell lysates of untreated isolated rat adipocytes was analyzed by immunoblotting. The caveolar structural and marker protein, caveolin 1, the GPI proteins Gce1 (glycolipid-anchored cAMP-binding ectoprotein) and 5'-nucleotidase (39, 43, 46), and the dual-acylated NRTK of the Src-class, pp59Lyn (52), were significantly enriched with DIG (versus total plasma membranes) prepared by either method (Table 1). The typical plasma membrane proteins, glucose transporter isoforms Glut1 and Glut4, IRbeta , and Na+/K+-ATPase were deprived from DIG areas (versus plasma membranes) and recovered mainly from non-DIG areas. Previous studies provided controversial data about the presence of Glut4 and the insulin receptor in caveolae-DIG from 3T3-L1 and rat adipocytes (24, 57). Furthermore, the present study revealed deprivement of Golgi-derived vesicles and clathrin-coated pits from both DIG and non-DIG areas based on their low content of COPII vesicle protein beta  and clathrin alpha -chain, respectively, relative to total plasma membranes (Table 1). Thus, cytoskeletal components, which are characterized by detergent insolubility, did not contaminate the DIG prepared by both methods to any significant degree. Based on the comparable enrichment and deprivement factors, DIG areas (and non-DIG areas) of qualitatively similar protein composition can be prepared by the carbonate and detergent methods.

                              
View this table:
[in this window]
[in a new window]
 
TABLE 1.   Characterization of DIG and non-DIG areas prepared by the carbonate and detergent methodsa

After dissociation of the DIG (detergent method) with octylglucoside plus deoxycholate (see Materials and Methods), 65 to 85% of pp59Lyn and pp125Fak present in DIG from basal adipocytes (as detected by immunoblotting of 1% SDS-solubilized DIG) was immunoprecipitated with caveolin 1. In contrast, less than 5% of Gce1 present in SDS-solubilized DIG was recovered with caveolin 1 immunoprecipitates from octylglucoside plus deoxycholate-dissociated DIG. This suggests a direct interaction between pp59Lyn-pp125Fak and caveolin 1 within caveolae-DIG which resists their dissociation by octylglucoside plus deoxycholate to a considerable degree but is disrupted by 60 mM octylglucoside plus 1% Nonidet P-40 (5 to 8% coimmunoprecipitation) or by 1% SDS (0.5 to 1% coimmunoprecipitation). In contrast, the localization of GPI proteins, such as Gce1, in caveolae-DIG apparently does not rely on direct binding to caveolin 1 but requires the intact structural organization of caveolae-DIG (in the presence of 1% Nonidet P-40 only). Thus, caveolin 1 (co)immunoprecipitates from nondissociated DIG harbor caveolar-DIG components irrespective of the molecular mechanism of their retention. Caveolin 1 immunoprecipitates from dissociated DIG recover only caveolin-interacting caveolar-DIG components. The conditions used for both immunoprecipitations result in efficient removal of noncaveolar plasma membrane polypeptides.

CBDP and PIG abrogate caveolin-pp59Lyn interaction and stimulate pp59Lyn and insulin-mimetic signaling. For demonstration of functional interaction between caveolin and NRTKs in DIG of the adipocyte plasma membrane, possibly mediated by the CSD and CBD, respectively (see Introduction), an excess of synthetic CBDP derived from pp59Lyn (Fig. 1) (41, 49) was introduced into isolated rat adipocytes by electroporation and analyzed for the effect on the association between caveolin and pp59Lyn residing in DIG (Fig. 2). The wild-type but not the mutant CBDP (Fig. 1) reduced in a concentration-dependent and drastic fashion the amount of caveolin which was coimmunoprecipitated with pp59Lyn and, vice versa, the amount of pp59Lyn which was coimmunoprecipitated with caveolin (Fig. 2). The apparent dissociation of pp59Lyn from caveolin residing in DIG was also reflected in the loss of pp59Lyn from total adipocyte caveolin immunoprecipitates as well as total (nondissociated) DIG in response to increasing concentrations of CBDP (Fig. 3A). It correlated well to pronounced increases in tyrosine phosphorylation and activity (toward exogenous substrate) of total immunoprecipitated pp59Lyn (Fig. 3B) as well as tyrosine phosphorylation of total cellular IRS-1 and pp125Fak with about the same concentration dependence (apparent 50% effective concentration [EC50] = 10 to 30 µM; Fig. 2). Homologous immunoblotting of the caveolin immunoprecipitates demonstrated similar efficiency of the immunoprecipitations. Stimulation of total IRS-1 tyrosine phosphorylation by wild-type but not mutant CBDP was strongly correlated to IRS-1-associated PI-3'K activity and glucose transport (Fig. 4). As expected, a control incubation of intact rat adipocytes with 300 µM CBDP omitting electroporation failed to induce pp59Lyn-caveolin dissociation and insulin-mimetic signaling, arguing for an intracellular site of action of CBDP.


View larger version (56K):
[in this window]
[in a new window]
 
FIG. 2.   Intracellular CBDP causes dissociation of pp59Lyn and caveolin in DIG. Isolated rat adipocytes were electroporated in the absence or presence of different concentrations of wild-type or mutant CBDP derived from pp59Lyn. From portions of total-cell lysates, DIG were prepared (detergent method) and used for immunoprecipitation (IP) (dissociating conditions) of pp59Lyn and caveolin. From other portions of the lysates, pp125Fak and IRS-1 were immunoprecipitated. The immunoprecipitates were immunoblotted (IB) for caveolin, pp59Lyn, and phosphotyrosine by immunoblotting using chemiluminescent detection. Shown are phosphorimages of a typical experiment that was repeated three times, with similar results.


View larger version (67K):
[in this window]
[in a new window]
 
FIG. 3.   CBDP and PIG affect pp59Lyn tyrosine phosphorylation and its activity and interaction with caveolin in a similar fashion. Isolated rat adipocytes were electroporated or incubated (20 min, 37°C) in the absence or presence of increasing concentrations of wild-type or mutant CBDP derived from pp59Lyn (A, B) or PIG 41 and PIG 1 (B). From portions of total-cell lysates, DIG were prepared (detergent method) and used for direct immunoblotting (IB) of pp59Lyn (A) or immunoprecipitation (IP) (nondissociating conditions) of caveolin (B). From other portions of the lysates, caveolin (A) and pp59Lyn (B) were immunoprecipitated. The immunoprecipitates were immunoblotted for pp59Lyn and phosphotyrosine (pY) or measured for pp59Lyn activity by the immune complex kinase assay. (A) Shown are phosphorimages of a typical experiment that was repeated two times, with similar results. (B) Quantitative evaluations of three different adipocyte incubations with measurements in triplicate each are given as the percentage of maximum or fold stimulation (mean plus standard deviation), with basal values set at 100% or 1.


View larger version (36K):
[in this window]
[in a new window]
 
FIG. 4.   Intracellular CBDP causes stimulation of IRS-1 tyrosine phosphorylation, PI-3'K, and glucose transport. Isolated rat adipocytes were electroporated in the absence or presence of increasing concentrations of wild-type CBDP derived from pp59Lyn. From portions of the cells, total lysates were prepared and used for immunoprecipitation (IP) of IRS-1. The immunoprecipitates were immunoblotted (IB) for phosphotyrosine (pY) or assessed for associated PI-3'K activity by the immune complex kinase assay. Other portions of the cells were assayed for 2-deoxyglucose transport. Quantitative evaluations of three different adipocyte incubations with measurements in quadruplicate each are given as fold stimulation (mean ± standard deviation), with basal values set at 1.

Interestingly, a similar decline in the interaction between pp59Lyn and caveolin in DIG and a concomitant increase in tyrosine phosphorylation and activation of total immunoprecipitated pp59Lyn was observed after incubation of rat adipocytes with the active insulin-mimetic PIG 41 (17, 18, 45) but not the inactive PIG 1 (Fig. 3B). However, about 100-fold-lower concentrations of PIG 41 than of wild-type CBDP were sufficient. This suggests that intracellular CBDP derived from pp59Lyn and exogenous active PIG trigger insulin-mimetic signaling and metabolic action in isolated rat adipocytes by similar mechanisms involving dissociation of pp59Lyn from caveolin in DIG. To test this hypothesis, DIG of isolated rat adipocytes incubated with structurally different PIG were assayed for caveolin-associated pp59Lyn, pp125Fak (by immunoblotting), and Gce1 (by photoaffinity labeling with 8-N3-[32P]cAMP; Fig. 5). The amounts of pp125Fak, pp59Lyn, and Gce1 recovered with caveolin immunoprecipitates from DIG were reduced by up to 60 and 80% in response to PIG 41 and 37, respectively (Fig. 5A and B). PIG 7 and 1 were less efficient (pp59Lyn and Gce1) or even inactive (pp125Fak). Comparable efficiency of caveolin immunoprecipitation was shown by homologous immunoblotting. Thus, the insulin-mimetic potency of active PIG correlates with their ability to disrupt the caveolin-pp59Lyn, -pp125Fak, and -Gce1 interactions.


View larger version (74K):
[in this window]
[in a new window]
 
FIG. 5.   PIG causes dissociation of pp125Fak, pp59Lyn, and Gce1 from caveolin in DIG. Isolated rat adipocytes were incubated (20 min, 37°C) with 10 µM PIG 41, 37, 7, or 1. DIG were prepared from total-cell lysates (detergent method) and used for immunoprecipitation (IP) (nondissociating conditions) of caveolin. The immunoprecipitates were immunoblotted (IB) for pp125Fak, pp59Lyn, and caveolin or assayed for Gce1 by photoaffinity labeling with 8-N3-[32P]cAMP. (A) Shown are phosphorimages of a typical experiment that was repeated two times, with similar results. (B) Quantitative evaluations of three different adipocyte incubations with measurements in triplicate each are given as the percent of maximal response (mean ± standard deviation), with basal values (absence of PIG) set at 100%.

Dissociation of this interaction by CBDP may be overcome by an excess of intracellular CSDP. In fact, the almost complete loss of Gce1 and pp125Fak along with pp59Lyn from caveolin residing in DIG upon introduction of CBDP into adipocytes was completely blocked by a simultaneous electroporation of a threefold molar excess of CSDP (Fig. 6). This argues for the neutralization of CBDP action by direct binding to CSDP. Apparently, CSDP not bound to CBDP does not compete with endogenous caveolin for interaction with CBD of pp59Lyn. This may be explained by a higher affinity of CSD in the context of native DIG-embedded caveolin. Excess of CSDP (up to 100-fold) impaired the PIG 41-induced release from DIG-associated caveolin of pp125Fak to only a low degree and that of pp59Lyn and Gce1 not at all (Fig. 6). Thus, CBDP and active PIG apparently differ in the mechanism interfering with the caveolin-signaling component interaction, PIG indirectly (possibly via signaling processes within caveolae-DIG) rather than physically.


View larger version (46K):
[in this window]
[in a new window]
 
FIG. 6.   CSDP blocks CBDP-induced but not PIG-induced dissociation of Gce1, pp59Lyn, and pp125Fak from caveolin. Isolated rat adipocytes were electroporated in the absence or presence of various concentrations of CSDP and/or CBDP and then were incubated (20 min, 37°C) with or without 3 µM PIG 41 as indicated. DIG were prepared from total-cell lysates (detergent method) and used for immunoprecipitation (IP) (nondissociating conditions) of caveolin. The immunoprecipitates were assessed for the presence of Gce1 by photoaffinity labeling and assessed for the presence of pp59Lyn and pp125Fak by immunoblotting (IB) using chemiluminescent detection. Shown are phosphorimages of a typical experiment that was repeated two times, with similar results.

Tyrosine phosphorylation of caveolin and its dissociation from pp59Lyn, pp125Fak, and Gce1 are correlated. The concentration-dependent dissociation of pp59Lyn, pp125Fak, and Gce1 from caveolin in DIG can also be followed with total adipocyte caveolin (Fig. 7). Upon treatment of adipocytes with different PIG, the decline in interaction correlated well to the increase in tyrosine phosphorylation of caveolin immunoprecipitated from total-cell lysates both with regard to the similar EC50 values (1 to 3 µM) and with the ranking between PIG 41 and 37. PIG 1 did not elicit caveolin tyrosine phosphorylation. Thus, in adipocytes, tyrosine phosphorylation of caveolin may be causally related to its dissociation from pp59Lyn, pp125Fak, and Gce1. Candidate kinases are Src family members since insulin-dependent caveolin tyrosine phosphorylation by pp60v-src and pp59Fyn has been described (22, 33, 36). In this case, a positive feedback loop between kinase activation and dissociation from caveolin and tyrosine phosphorylation of caveolin may be initiated.


View larger version (47K):
[in this window]
[in a new window]
 
FIG. 7.   PIG-induced dissociation of Gce1, pp125Fak, and pp59Lyn from caveolin correlates to caveolin tyrosine phosphorylation. Isolated rat adipocytes were incubated (20 min, 37°C) with increasing concentrations of PIG 41, 37, or 1. From total-cell lysates, caveolin was immunoprecipitated (IP). The immunoprecipitates were assayed for the presence of Gce1 by photoaffinity labeling or for the presence of pp125Fak, pp59Lyn, phosphotyrosine (pY), and caveolin by immunoblotting (IB). Shown are quantitative evaluations of three different adipocyte incubations with measurements taken in quadruplicate, and results are given as a ratio of the relative amount of caveolin (mean ± standard deviation) or as the fold stimulation (mean ± standard deviation), with basal values set at 1.

CSDP blocks PIG-induced tyrosine phosphorylation and glucose transport activation. In agreement with the caveolin signaling hypothesis (34, 49), the above data hint to a negative regulatory function of caveolin on pp59Lyn. To further substantiate the involvement of caveolin in pp59Lyn inhibition and its antagonism by active PIG, we studied the effect of CSDP on pp59Lyn tyrosine phosphorylation (Fig. 8A) and downstream signaling events (Fig. 8B) after introduction into isolated rat adipocytes. As demonstrated previously (44), PIG 7, 37, and 41 induced tyrosine phosphorylation of total immunoprecipitated pp59Lyn in a concentration-dependent fashion, with PIG 41 being most effective, followed by PIG 37 and, lastly, PIG 7. PIG-induced tyrosine phosphorylation was reduced by wild-type CSDP in a concentration-dependent fashion, with a 50% inhibitory concentration of 30 µM irrespective of the PIG concentration used (Fig. 8A and B). Inhibition of tyrosine phosphorylation of total immunoprecipitated pp59Lyn, pp125Fak, and IRS-1 as well as glucose transport in response to PIG 41 (2 µM) by CSDP were well correlated (Fig. 8B). Thus, cytoplasmic wild-type CSDP can act as an efficient inhibitor of PIG stimulation of pp59Lyn, insulin-mimetic signaling (IRS-1 tyrosine phosphorylation), and insulin-mimetic action (glucose transport based on translocation of Glut4 and Glut1 from intracellular vesicles to the plasma membrane as reported previously [18]). Since CSDP does not interfere with PIG-induced release of pp59Lyn and pp125Fak from caveolin (Fig. 6), it presumably acts via dominant-negative binding to pp59Lyn upon relief of the latter from inhibition by endogenous caveolin.


View larger version (92K):
[in this window]
[in a new window]
 
FIG. 8.   CSDP impairs PIG-induced tyrosine phosphorylation of pp59Lyn (A) and tyrosine phosphorylation of pp125Fak and IRS-1 and glucose transport (B). Isolated rat adipocytes were electroporated in the absence of CSDP or presence of increasing concentrations of CSDP and then incubated (20 min, 37°C) with increasing concentrations of PIG 41, 37, and 7 (A) or 2 µM PIG 41 (B). From portions of the cells, pp59Lyn (A, B) and pp125Fak and IRS-1 (B) were immunoprecipitated (IP) from total-cell lysates and were immunoblotted (IB) for phosphotyrosine (pY). (A) Shown are phosphorimages of a typical experiment that was repeated three times, with similar results. (B) Other portions of the cells were assayed for 2-deoxyglucose transport. Shown are quantitative evaluations of four different adipocyte incubations with measurements in duplicate, and results are given as the percent of PIG response (mean ± standard deviation), set at 100% in the absence of CSDP.

PIG trigger redistribution of pp59Lyn, pp125Fak, and Gce1 from DIG to non-DIG areas. The observation that active PIG trigger the dissociation of a specific set of proteins from caveolin in adipocytes raised the question about their destination. Therefore, we studied whether these polypeptides leave the DIG and move to other regions of the plasma membrane which do not harbor DIG according to the criterion of detergent or carbonate insolubility (non-DIG areas) or translocate to intracellular membranes or the cytosol. The non-DIG areas are characterized by significant deprivement of caveolin, 5'-nucleotidase, Gce1, and pp59Lyn versus both total plasma membranes and DIG, as well as significant enrichment of Na+/K+-ATPase and beta -actin versus DIG (Table 1). Glut1, Glut4, and IRbeta were distributed about equally between DIG and non-DIG areas. Thus, in isolated rat adipocytes, non-DIG areas represent the typical overall plasma membranes harboring the majority of plasma membrane proteins but lacking typical caveolar or DIG components. Figure 9A demonstrates that the concentration-dependent decrease in the amount of Gce1, pp59Lyn, and pp125Fak in DIG in response to PIG 41 was in parallel to their increase in non-DIG areas isolated from the same adipocytes. Quantitative evaluation confirmed the inverse relationship between the disappearance and appearance of Gce1, pp59Lyn, and pp125Fak in DIG and non-DIG areas, respectively, in response to PIG 41 with similar EC50 (0.3 to 1 µM) for all three proteins (Fig. 9B). PIG treatment did not affect the distribution of caveolin, IRbeta , and Glut4 between DIG (Fig. 9A) and non-DIG areas and was not associated with a considerable shift of Gce1, pp59Lyn, and pp125Fak to intracellular membranes or the cytosol (data not shown). In agreement with the failure of CSDP to impair the PIG-induced dissociation of pp59Lyn from caveolin (Fig. 6), a 30-fold molar excess of CSDP over PIG 41 did not affect redistribution of pp59Lyn from DIG to non-DIG areas (Fig. 10). Taken together, active PIG trigger pronounced redistribution of Gce1, pp59Lyn, and pp125Fak from DIG to non-DIG areas of the adipocyte plasma membrane.


View larger version (74K):
[in this window]
[in a new window]
 
FIG. 9.   PIG induces redistribution of Gce1, pp59Lyn, and pp125Fak from DIG to non-DIG areas of the plasma membrane. Isolated rat adipocytes were incubated (20 min, 37°C) with increasing concentrations of PIG 41. From total plasma membranes, DIG and non-DIG areas were prepared (carbonate method), purified (sucrose gradient centrifugation), and then immunoblotted (IB) for pp59Lyn, pp125Fak, caveolin, IRbeta , and Glut4 or assayed for Gce1 by photoaffinity labeling. (A) Shown are phosphorimages of a typical experiment that was repeated two times, with similar results. (B) Shown are quantitative evaluations of three different adipocyte incubations with measurements in duplicate, and results are given as the percentage of total material contained in DIG (open circle ) plus non-DIG () areas (mean ± standard deviation), with basal values (absence of PIG 41) set at 100%.


View larger version (59K):
[in this window]
[in a new window]
 
FIG. 10.   CSDP does not interfere with PIG-induced redistribution of pp59Lyn from DIG to non-DIG areas. Isolated rat adipocytes were electroporated in the absence or presence of 300 µM CSDP and then incubated (20 min, 37°C) with increasing concentrations of PIG 41. From total plasma membranes, DIG and non-DIG areas were prepared (carbonate method), purified (sucrose gradient centrifugation), and then immunoblotted (IB) for pp59Lyn. Shown are phosphorimages of a typical experiment that was repeated once, with similar results.

pp125Fak interacts with pp59Lyn, IRS-1, and Gce1 during PIG-induced redistribution. Previous studies on the mechanism of insulin receptor-independent tyrosine phosphorylation of IRS-1 in response to PIG showed that pp125Fak acts as a platform molecule for PIG-dependent recruitment of pp59Lyn and IRS-1 (44). The present observation of PIG-dependent redistribution of pp59Lyn, Gce1, and pp125Fak raised the possibility of their interaction after arrival at non-DIG areas. In fact, treatment of isolated rat adipocytes with PIG 41 increased, in a concentration-dependent manner, the amounts of pp59Lyn, Gce1, and IRS-1 which were coimmunoprecipitated with pp125Fak from non-DIG areas (Fig. 11). The efficiency of pp125Fak immunoprecipitation did not vary significantly. The (small) amounts of beta 1-integrin, paxillin (a major cytoskeletal substrate of pp125Fak), and IRbeta recovered with pp125Fak in non-DIG areas did not elevate during the course of PIG treatment. Thus, PIG-stimulated redistribution of pp59Lyn and Gce1 from DIG to non-DIG areas is accompanied by their association with pp125Fak and IRS-1. This provides further evidence for pp125Fak functioning as a recruitment platform during PIG signaling.


View larger version (67K):
[in this window]
[in a new window]
 
FIG. 11.   PIG induces complex formation between pp125Fak, pp59Lyn, IRS-1, paxillin, and Gce1. Isolated rat adipocytes were incubated (20 min, 37°C) in the absence or presence of increasing concentrations of PIG 41. From total-cell lysates, non-DIG areas were prepared (detergent method) and then used for immunoprecipitation (IP) (nondissociating conditions) of pp125Fak. The immunoprecipitates were subsequently immunoblotted (IB) for pp125Fak, beta 1-integrin, pp59Lyn, IRS-1, paxillin, and IRbeta or assayed for Gce1 by photoaffinity labeling. Shown are phosphorimages of a typical experiment that was repeated two times, with similar results.

CSDP does not block insulin signaling and action. Insulin has been reported to cause partial activation of NRTK of the Src family (pp59Fyn) in 3T3-L1 adipocytes (29, 36). However, its relevance for metabolic insulin action remained unclear. It was conceivable that insulin and PIG activation of PI-3'K operate in part via the same molecular mechanism. Therefore, we studied whether CSDP manages to inhibit insulin stimulation of glucose transport and IRS-1 tyrosine phosphorylation (Table 2). As expected, electroporation of isolated rat adipocytes with CSDP inhibited, in a concentration-dependent manner, IRS-1 tyrosine phosphorylation and glucose transport activation in response to both CBDP and PIG 41. In contrast, CSDP failed to suppress insulin signaling and metabolic action to any significant degree, even at 300 µM and at submaximal insulin concentrations. This argues for the specificity of the CSDP inhibitory action and strongly suggests that insulin does not use the same signaling pathway upstream of IRS-1 as active PIG involving the modulation of the caveolin-pp59Lyn interaction.

                              
View this table:
[in this window]
[in a new window]
 
TABLE 2.   Effect of CSDP on glucose transport stimulation by PIG, CBDP, and insulina


    DISCUSSION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

It has been proposed that caveolins and, by implication, caveolae and DIG may act to coordinate the interaction of receptors and a variety of downstream signal-transducing molecules that localize to the plasma membrane following cell stimulation (41, 49, 60). Agonist stimulation has been demonstrated to result in redistribution of receptors for contractile agonists (e.g., bradykinin [13] and acetylcholine [16]), hormones (e.g., insulin [24] and angiotensin II [25]), and growth factors (e.g., epidermal growth factor [11]), as well as of downstream elements (e.g., protein kinase Calpha [37] and rhoA [63]) to caveolin-containing subcellular fractions, which for rhoA was shown to be inhibited by the CSDP (63).

Our studies with isolated rat adipocytes have revealed the induction and regulation of the opposite movement of signaling components. The NRTK, pp59Lyn, pp125Fak, and the GPI protein, Gce1, translocate from DIG to non-DIG areas of the plasma membrane in response to (i) an extracellular stimulus, insulin-mimetic PIG molecules, and (ii) intracellular accumulation of CBDP derived from pp59Lyn. This movement is based on interference (indirectly or directly, respectively) with the caveolin(CSD)-NRTK(CBD) interaction. It correlates well to increased tyrosine phosphorylation and activity of pp59Lyn and pp125Fak and is accompanied by elevated tyrosine phosphorylation of IRS-1, PI-3'K activity, and glucose transport. In contrast, CSDP blocked PIG-induced tyrosine phosphorylation of pp59Lyn, pp125Fak, and IRS-1 as well as glucose transport and can therefore be used as a specific inhibitor to test for involvement of the PIG signaling pathway. These findings suggest a causal relationship between the interaction with caveolin, localization in DIG-caveolae, and low activity of Gce1, pp59Lyn, and pp125Fak and vice versa between their dissociation from caveolin, redistribution from DIG-caveolae to plasma membrane non-DIG areas, and insulin-mimetic signaling.

In vivo, PIG molecules as a putative physiological signal may be generated by lipolytic cleavage of GPI proteins at the outer face of the plasma membrane, which, in fact, has been reported for primary and cultured adipose, muscle, and endothelial cells in response to a number of hormones and growth factors, such as insulin and nerve growth factor (38, 39), glucose (1, 39), and the drug glimepiride (38, 39). Alternatively, degradation products of free GPI lipids concentrated in DIG-caveolae may act in a similar fashion as the synthetic PIG used in the present study. In different cellular systems, lipolytic GPI turnover is modulated by a variety of hormones, cytokines, and growth factors, such as insulin, interleukin-2, epidermal growth factor, and erythropoietin (4, 9, 26). Treatment of intact rat adipocytes with bacterial (G)PI-specific phospholipase C induces some insulin effects (35) and tyrosine phosphorylation of caveolin but not of the insulin receptor (42). However, redistribution of caveolar components in response to GPI cleavage remains to be studied.

pp125Fak released from DIG-caveolae is phosphorylated at tyrosines, presumably in an autophosphorylation reaction (Tyr397) and by pp59Lyn (Tyr576, Tyr577). This ensures proper interaction of the two kinases (6) and maximal activation of pp125Fak (44), respectively. pp125Fak is known to function as a platform molecule for signal-dependent recruitment of a number of signaling molecules, including IRS-1 and IRS-2 (62). This finding was confirmed and extended here by the demonstration of complex formation between pp125Fak, pp59Lyn, IRS-1, and Gce1, but not the cytoskeletal proteins, paxillin, and beta 1-integrin, in response to PIG. Thus, Gce1, pp59Lyn, and pp125Fak together with IRS-1 and IRS-2 may be redistributed from caveolae to a multicomponent signaling module where tyrosine-phosphorylated and activated pp125Fak may present IRS-1 and IRS-2 for phosphorylation at specific tyrosine residues by activated pp59Lyn. This in turn initiates signaling to the Glut4 and Glut1 translocation apparatus and other metabolic effector systems which also receive their insulin signals from the IRS proteins (23, 47). Apparently, IRS-1 acts as site of convergence of the signaling pathways initiated by insulin-mimetic PIG and insulin. These are clearly separate upstream of IRS-1 based on the ability of CSDP to block PIG but not insulin signaling and action. It is clear from studies with CSDP that relief of pp59Lyn from interaction with or inhibition by caveolin is required for insulin-mimetic PIG signaling and action. However, the signal emerging from this pathway and ultimately resulting in potent PI-3'K activation may not be sufficient for glucose transport stimulation by PIG. Furthermore, the PIG pathway may operate not only in adipose but also muscle cells since they both express a high number of caveolae (2), which is a prerequisite and may guarantee specificity for metabolic coupling. Future experiments have to address these possibilities.

The PIG signaling module upstream of IRS-1 seems to be used by other ligands or pathways since clustering of the adipocyte-specific integrins alpha 5 and beta 1 by fibronectin plus activating anti-beta 1-antibody blocked PIG-induced tyrosine phosphorylation of pp59Lyn and IRS-1 via interference at pp125Fak (44). Thus, the Gce1-pp125Fak-pp59Lyn-IRS-1-IRS-2 complex may represent the site for the integration of at least two pathways for extracellular signals leading to insulin-mimetic metabolic signaling. One of the pathways acts from GPI proteins via caveolae-DIG in a positive fashion, and the other pathway acts from the extracellular matrix via integrins in a negative fashion. Localization of the activated signaling module at sites different from both caveolae-DIG and integrins at non-DIG areas may favor this cross talk.

Our finding may be of relevance for the elucidation of novel approaches for the therapy of insulin-resistant states which are manifested during metabolic syndrome and type II diabetes mellitus (8). Reduced responsiveness and sensitivity of components of the insulin signaling pathway toward insulin can be observed already immediately downstream of the insulin receptor at the level of tyrosine phosphorylation of IRS-1 and IRS-2 (30). Consequently, insulin receptor-independent tyrosine phosphorylation of IRS-1 and IRS-2 mediated by cross talk from the GPI protein-DIG-caveola-pp59Lyn pathway should induce insulin-mimetic effects, such as stimulation of glucose uptake, in insulin-resistant adipose and muscle cells. This has been demonstrated so far for PIG in adipocytes isolated from obese rats (18). Thus, small molecules which cause redistribution of caveolar or DIG components may be useful for the therapy of metabolic syndrome and type II diabetes mellitus.


    FOOTNOTES

* Corresponding author. Mailing address: Aventis Pharma Germany GmbH, Disease Group Metabolic Diseases, Bldg. H825, 65926 Frankfurt am Main, Germany. Phone: 4969-305-4271. Fax: 4969-305-81901. E-mail: Guenter.Mueller{at}aventis.com.


    REFERENCES
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

1. Accardo-Palumbo, A., G. Triolo, G. Colonna-Romano, M. Potestio, M. Carbone, A. Ferrante, E. Giardina, G. Caimi, and G. Triolo. 2000. Glucose-induced loss of glycosyl-phosphatidylinositol-anchored membrane regulators of complement activation (CD59, CD55) by in vitro cultured human umbilical vein endothelial cells. Diabetologia 43:1039-1047[CrossRef][Medline].
2. Anderson, R. G. W. 1998. The caveolae membrane system. Annu. Rev. Biochem. 67:199-225[CrossRef][Medline].
3. Bickel, P. E., P. E. Scherer, J. E. Schnitzer, P. Oh, M. P. Lisanti, and H. F. Lodish. 1997. Flotillin and epidermal surface antigen define a new famly of caveolae-associated integral membrane proteins. J. Biol. Chem. 272:13793-13802[Abstract/Free Full Text].
4. Boudot, C., E. Petitfrere, Z. Kadri, S. Chretien, P. Mayeux, B. Haye, and C. Billat. 1999. Erythropoietin induces glycosylphosphatidylinositol hydrolysis. J. Biol. Chem. 274:33966-33972[Abstract/Free Full Text].
5. Brown, D. A., and E. London. 1998. Structure and origin of ordered lipid domains in biological membranes. J. Membr. Biol. 164:103-114[CrossRef][Medline].
6. Calalb, M. B., T. R. Polte, and S. K. Hanks. 1995. Tyrosine phosphorylation of focal adhesion kinase at sites in the catalytic domain regulates kinase activity: a role for Src family kinases. Mol. Cell. Biol. 15:954-963[Abstract].
7. Carman, C. V., M. P. Lisanti, and J. L. Benovic. 1999. Regulation of G protein-coupled receptor kinases by caveolin. J. Biol. Chem. 274:8858-8864[Abstract/Free Full Text].
8. Carvalho, E., B. Eliasson, C. Wesslau, and U. Smith. 2000. Impaired phosphorylation and insulin-stimulated translocation to the plasma membrane of protein kinase B/Akt in adipocytes from type II diabetic subjects. Diabetologia 43:1107-1115[CrossRef][Medline].
9. Clemente, R., D. R. Jones, P. Ochoa, G. Romero, J. M. Mato, and I. Varela-Nieto. 1995. Role of glycosyl-phosphatidylinositol hydrolysis as a mitogenic signal for epidermal growth factor. Cell. Signal. 7:411-421[CrossRef][Medline].
10. Couet, J., S. Li, T. Okamoto, T. Ikezu, and M. P. Lisanti. 1997. Identification of peptide and protein ligands for the caveolin-scaffolding domain. J. Biol. Chem. 272:6525-6533[Abstract/Free Full Text].
11. Couet, J., M. Sargiacomo, and M. P. Lisanti. 1997. Interaction of a receptor tyrosine kinase, EGF-R, with caveolins. Caveolin binding negatively regulates tyrosine and serine/threonine kinase activities. J. Biol. Chem. 272:30429-30438[Abstract/Free Full Text].
12. Das, K., R. Y. Lewis, P. E. Scherer, and M. P. Lisanti. 1999. The membrane spanning domains of caveolins 1 and 2 mediate the formation of caveolin hetero-oligomers. Implications for the assembly of caveolae membranes in vivo. J. Biol. Chem. 274:18721-18726[Abstract/Free Full Text].
13. de Weerd, W. F. C., and L. M. F. Leeb-Lundberg. 1997. Bradykinin sequesters B2 bradykinin receptors and the receptor coupled Galpha subunits Galpha q and Galpha i in caveolae in DDT1 MF-2 smooth muscle cells. J. Biol. Chem. 272:17858-17866[Abstract/Free Full Text].
14. Engelman, J. A., C. Chu, A. Lin, H. Jo, T. Ikezu, T. Okamoto, D. S. Kohtz, and M. P. Lisanti. 1998. Caveolin-mediated regulation of signaling along the p42/44 MAP kinase cascade in vivo. A role for the caveolin-scaffolding domain. FEBS Lett. 428:205-211[CrossRef][Medline].
15. Engelman, J. A., C. C. Wykoff, S. Yasuhara, K. S. Song, T. Okamoto, and M. P. Lisanti. 1997. Recombinant expression of caveolin-1 in oncogenically transformed cells abrogates anchorage-independent growth. J. Biol. Chem. 272:16374-16381[Abstract/Free Full Text].
16. Feron, O., T. W. Smith, T. Michel, and R. A. Kelly. 1997. Dynamic targeting of the agonist-stimulated m2 muscarinic acetylcholine receptor to caveolae in cardiac myocytes. J. Biol. Chem. 272:17744-17748[Abstract/Free Full Text].
17. Frick, W., A. Bauer, J. Bauer, S. Wied, and G. Müller. 1998. Insulin-mimetic signalling of synthetic phosphoinositolglycans in isolated rat adipocytes. Biochem. J. 336:163-181.
18. Frick, W., A. Bauer, J. Bauer, S. Wied, and G. Müller. 1998. Structure-activity relationship of synthetic phosphoinositolglycans mimicking metabolic insulin action. Biochemistry 37:13421-13436[CrossRef][Medline].
19. Galbiati, F., D. Volonte, J. A. Engelman, G. Watanabe, R. Burk, R. G. Pestell, and M. P. Lisanti. 1998. Targeted downregulation of caveolin-1 is sufficient to drive cell transformation and hyperactivate the p42/44 MAP kinase cascade. EMBO J. 17:6633-6648[CrossRef][Medline].
20. Garcia-Cardena, G., P. Martasek, B. S. Siler-Masters, P. M. Skidd, J. C. Couet, S. Li, M. P. Lisanti, and W. C. Sessa. 1997. Dissecting the interaction between nitric oxide synthase (NOS) and caveolin: functional significance of the NOS caveolin binding domain in vivo. J. Biol. Chem. 272:25437-25440[Abstract/Free Full Text].
21. Glenney, J. R. 1992. The sequence of human caveolin reveals identity with VIP 21, a component of transport vesicles. FEBS Lett. 314:45-48[CrossRef][Medline].
22. Glenney, J. R. 1989. Tyrosine phosphorylation of a 22 kD protein is correlated with transformation with Rous sarcoma virus. J. Biol. Chem. 264:20163-20166[Abstract/Free Full Text].
23. Gustafson, T. A., S. A. Moodie, and B. E. Lavan. 1998. The insulin receptor and metabolic signaling. Rev. Physiol. Biochem. Pharmacol. 137:71-192.
24. Gustavsson, J., S. Parpal, M. Karlsson, C. Ramsing, H. Thorn, M. Borg, M. Lindroth, K. H. Peterson, K.-E. Magnusson, and P. Stralfors. 1999. Localization of the insulin receptor in caveolae of adipocyte plasma membrane. FASEB J. 13:1961-1971[Abstract/Free Full Text].
25. Ishizaka, N., K. K. Griendling, B. Lassegue, and R. W. Alexander. 1998. Angiotensin II type 1 receptor: relationship with caveolae and caveolin after initial agonist stimulation. Hypertension 32:459-466[Abstract/Free Full Text].
26. Jones, D. R., and I. Varela-Nieto. 1999. Diabetes and the role of inositol-containing lipids in insulin signaling. Mol. Med. 5:505-514[Medline].
27. Ju, H., R. Zou, V. J. Venema, and R. C. Venema. 1997. Direct interaction of endothelial nitric-oxide synthase and caveolin-1 inhibits synthase activity. J. Biol. Chem. 272:18522-18525[Abstract/Free Full Text].
28. Koleske, A., J. D. Baltimore, and M. P. Lisanti. 1995. Reduction of caveolin and caveolae in oncogenically transformed cells. Proc. Natl. Acad. Sci. USA 92:1381-1385[Abstract/Free Full Text].
29. Lebrun, P., I. Mothe-Satney, L. Delahaye, E. van Obberghen, and V. Baron. 1998. Insulin receptor substrate-1 as a signaling molecule for focal adhesion kinase pp125Fak and pp60src. J. Biol. Chem. 273:32244-32253[Abstract/Free Full Text].
30. Le Marchand-Brustel, Y., J.-F. Tanti, M. Cormont, J.-M. Ricort, T. Gremeaux, and S. Grillo. 1999. From insulin receptor signalling to GLUT4 translocation abnormalities in obesity and insulin resistance. J. Recept. Signal Transduct. Res. 19:217-228[Medline].
31. Li, S., J. Couet, and M. P. Lisanti. 1996. Src tyrosine kinases, Galpha subunits, and H-Ras share a common membrane-anchored scaffolding protein, caveolin. Caveolin binding negatively regulates the auto-activation of Src tyrosine kinases. J. Biol. Chem. 272:29182-29190.
32. Li, S., T. Okamoto, M. Chun, M. Sargiacomo, J. E. Casanova, S. H. Hansen, I. Nishimoto, and M. P. Lisanti. 1995. Evidence for a regulated interaction between heteromeric G proteins and caveolin. J. Biol. Chem. 270:15693-15701[Abstract/Free Full Text].
33. Li, S., R. Seitz, and M. P. Lisanti. 1996. Phosphorylation of caveolin by Src tyrosine kinases: the alpha-isoform of caveolin is selectively phosphorylated by v-Src in vivo. J. Biol. Chem. 271:3863-3868[Abstract/Free Full Text].
34. Lisanti, M. P., P. E. Scherer, Z. L. Tang, and M. Sargiacomo. 1994. Caveolae, caveolin and caveolin-rich membrane domains: a signaling hypothesis. Trends Cell Biol. 4:231-235[CrossRef][Medline].
35. Macaulay, S. L., and R. G. Larkins. 1990. Phospholipase C mimics insulin action on pyruvate dehydrogenase and insulin mediator generation but not glucose transport or utilization. Cell. Signal. 2:9-19[CrossRef][Medline].
36. Mastick, C. C., M. J. Brady, and A. R. Saltiel. 1995. Insulin stimulates the tyrosine phosphorylation of caveolin. J. Cell Biol. 129:1523-1531[Abstract/Free Full Text].
37. Mineo, C., Y.-S. Ying, C. Chapline, S. Jaken, and R. G. W. Anderson. 1998. Targeting of protein kinase C alpha to caveolae. J. Cell Biol. 141:601-610[Abstract/Free Full Text].
38. Movahedi, S., and N. Hooper. 1997. Insulin stimulates the release of the glycosyl phosphatidylinositol-anchored membrane dipeptidase from 3T3-L1 adipocytes through the action of a phospholipase C. Biochem. J. 326:531-537.
39. Müller, G., E.-A. Dearey, A. Korndörfer, and W. Bandlow. 1994. Stimulation of a glycosyl phosphatidylinositol-specific phospholipase by insulin and the sulfonylurea, glimepiride, in rat adipocytes depends on increased glucose transport. J. Cell Biol. 126:1267-1276[Abstract/Free Full Text].
40. Müller, G., J. Ertl, M. Gerl, and G. Preibisch. 1997. Leptin impairs metabolic actions of insulin in isolated rat adipocytes. J. Biol. Chem. 272:10585-10593[Abstract/Free Full Text].
41. Müller, G., and W. Frick. 1999. Signalling via caveolin: involvement in the cross-talk between phosphoinositolglycans and insulin. Cell. Mol. Life Sci. 56:945-970[CrossRef][Medline].
42. Müller, G., and K. Geisen. 1996. Characterization of the molecular mode of the sulfonylurea, glimepiride, at adipocytes. Horm. Metab. Res. 28:469-487[Medline].
43. Müller, G., E.-A. Wetekam, C. Jung, and W. Bandlow. 1994. Membrane association of lipoprotein lipase and a cAMP-binding ectoprotein in rat adipocytes. Biochemistry 33:12149-12159[CrossRef][Medline].
44. Müller, G., S. Wied, and W. Frick. 2000. Cross talk of pp125FAK and pp59Lyn non-receptor tyrosine kinases to insulin-mimetic signaling in adipocytes. Mol. Cell. Biol. 20:4708-4723[Abstract/Free Full Text].
45. Müller, G., S. Wied, C. Piossek, A. Bauer, J. Bauer, and W. Frick. 1998. Convergence and divergence of the signaling pathways for insulin and phosphoinositolglycans. Mol. Med. 4:299-323[Medline].
46. Nosjean, O., A. Briolay, and B. Roux. 1997. Mammalian GPI proteins: sorting, membrane residence and functions. Biochim. Biophys. Acta 1331:153-186[Medline].
47. Nystrom, F. H., and M. J. Quon. 1999. Insulin signalling: metabolic pathways and mechanisms for specificity. Cell. Signal. 11:563-574[CrossRef][Medline].
48. Oka, N., M. Yamamoto, C. Schwencke, J. Kawabe, T. Ebina, S. Ohno, J. Couet, M. P. Lisanti, and Y. Ishikawa. 1997. Caveolin interaction with protein kinase C. Isoenzyme-dependent regulation of kinase activity by the scaffolding domain peptide. J. Biol. Chem. 272:33416-33421[Abstract/Free Full Text].
49. Okamoto, T., A. Schlegel, P. E. Scherer, and M. P. Scherer. 1998. Caveolins, a family of scaffolding proteins for organizing "preassembled signaling complexes" at the plasma membrane. J. Biol. Chem. 273:5419-5422[Free Full Text].
50. Parton, R. G. 1996. Caveolae and caveolins. Curr. Opin. Cell Biol. 8:542-548[CrossRef][Medline].
51. Razani, B., C. S. Rubin, and M. P. Lisanti. 1999. Regulation of cAMP-mediated signal transduction via interaction of caveolins with the catalytic subunit of protein kinase A. J. Biol. Chem. 274:26353-26360[Abstract/Free Full Text].
52. Resh, M. D. 1998. Fyn, a Src family tyrosine kinase. Int. J. Biochem. Cell Biol. 30:1159-1162[CrossRef][Medline].
53. Rietveld, A., and K. Simons. 1998. The differential miscibility of lipids as the basis for the formation of functional membrane rafts. Biochim. Biophys. Acta 1376:467-479[Medline].
54. Rothberg, K. G., J. E. Henser, W. C. Donzell, Y.-S. Ying, J. R. Glenney, and R. G. W. Anderson. 1992. Caveolin, a protein component of caveolae membrane coats. Cell 68:673-682[CrossRef][Medline].
55. Sargiacomo, M., M. Sudol, Z. L. Tang, and M. P. Lisanti. 1993. Signal transducing molecules and glycosyl-phosphatidylinositol-linked proteins form a caveolin-rich insoluble complex in MDCK cells. J. Cell Biol. 122:789-807[Abstract/Free Full Text].
56. Scherer, P. E., R. Y. Lewis, D. Volonte, J. A. Engelman, F. Galbiati, J. Couet, D. S. Kohtz, E. van Donselaar, P. Peters, and M. P. Lisanti. 1997. Cell-type and tissue-specific expression of caveolin-2. Caveolin 1 and 2 co-localize and form a stable hetero-oligomeric complex in vivo. J. Biol. Chem. 272:29337-29346[Abstract/Free Full Text].
57. Scherer, P. E, M. P. Lisanti, G. Baldini, M. Sargiacomo, C. C. Mastick, and H. F. Lodish. 1994. Induction of caveolin during adipogenesis and association of GLUT4 with caveolin-rich vesicles. J. Cell Biol. 127:1233-1243[Abstract/Free Full Text].
58. Schlegel, A., D. Volonte, and J. A. Engelmann. 1999. Crowded little caves: structure and function of caveolae. Cell. Signal. 10:457-463.
59. Shaul, P. W., and R. G. Anderson. 1998. Role of plasmalemmal caveolae in signal transduction. Am. J. Physiol. 275:L843-L851[Abstract/Free Full Text].
60. Smart, E. J., G. A. Graf, M. A. McNiven, W. C. Sessa, J. A. Engelman, P. E. Scherer, T. Okamoto, and M. P. Lisanti. 1999. Caveolins, liquid-ordered domains, and signal transduction. Mol. Cell. Biol. 19:7289-7304[Free Full Text].
61. Song, K. S., S. Li, T. Okamoto, L. Quilliam, M. Sargiacomo, and M. P. Lisanti. 1996. Copurification and direct interaction of Ras with caveolin, an integral membrane protein of caveolae microdomains. Detergent free purification of caveolae membranes. J. Biol. Chem. 271:9690-9697[Abstract/Free Full Text].
62. Sun, X. J., S. Pons, T. Asano, M. G. Myers, E. Glasheen, and M. F. White. 1996. The Fyn tyrosine kinase binds Irs-1 and forms a distinct signaling complex during insulin stimulation. J. Biol. Chem. 271:10583-10587[Abstract/Free Full Text].
63. Taggert, M. J., P. Leavis, O. Feron, and K. G. Morgan. 2000. Inhibition of PKCalpha and rhoA translocation in differentiated smooth muscle by a caveolin scaffolding domain peptide. Exp. Cell Res. 258:72-81[CrossRef][Medline].


Molecular and Cellular Biology, July 2001, p. 4553-4567, Vol. 21, No. 14
0270-7306/01/$04.00+0   DOI: 10.1128/MCB.21.14.4553-4567.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Muller, G., Wied, S., Walz, N., Jung, C. (2008). Translocation of Glycosylphosphatidylinositol-Anchored Proteins from Plasma Membrane Microdomains to Lipid Droplets in Rat Adipocytes Is Induced by Palmitate, H2O2, and the Sulfonylurea Drug Glimepiride. Mol. Pharmacol. 73: 1513-1529 [Abstract] [Full Text]  
  • Krebs, B., Kohlmannsperger, V., Nolting, S., Schmalzbauer, R., Kretzschmar, H. A. (2006). A Method to Perform Western Blots of Microscopic Areas of Histological Sections. J. Histochem. Cytochem. 54: 559-565 [Abstract] [Full Text]  
  • Chen, G., Liu, P., Pattar, G. R., Tackett, L., Bhonagiri, P., Strawbridge, A. B., Elmendorf, J. S. (2006). Chromium Activates Glucose Transporter 4 Trafficking and Enhances Insulin-Stimulated Glucose Transport in 3T3-L1 Adipocytes via a Cholesterol-Dependent Mechanism. Mol. Endocrinol. 20: 857-870 [Abstract] [Full Text]  
  • Liu, J., DeYoung, S. M., Zhang, M., Dold, L. H., Saltiel, A. R. (2005). The Stomatin/Prohibitin/Flotillin/HflK/C Domain of Flotillin-1 Contains Distinct Sequences That Direct Plasma Membrane Localization and Protein Interactions in 3T3-L1 Adipocytes. J. Biol. Chem. 280: 16125-16134 [Abstract] [Full Text]  
  • Kabayama, K., Sato, T., Kitamura, F., Uemura, S., Kang, B. W., Igarashi, Y., Inokuchi, J.-i. (2005). TNF{alpha}-induced insulin resistance in adipocytes as a membrane microdomain disorder: involvement of ganglioside GM3. Glycobiology 15: 21-29 [Abstract] [Full Text]  
  • Uhles, S., Moede, T., Leibiger, B., Berggren, P.-O., Leibiger, I. B. (2003). Isoform-specific insulin receptor signaling involves different plasma membrane domains. JCB 163: 1327-1337 [Abstract] [Full Text]  
  • Cohen, A. W., Combs, T. P., Scherer, P. E., Lisanti, M. P. (2003). Role of caveolin and caveolae in insulin signaling and diabetes. Am. J. Physiol. Endocrinol. Metab. 285: E1151-E1160 [Abstract] [Full Text]  
  • Biedi, C., Panetta, D., Segat, D., Cordera, R., Maggi, D. (2003). Specificity of Insulin-Like Growth Factor I and Insulin on Shc Phosphorylation and Grb2 Recruitment in Caveolae. Endocrinology 144: 5497-5503 [Abstract] [Full Text]  
  • Kwon, Y.-K., Jang, H.-J., Kole, S., He, H.-J., Bernier, M. (2003). Role of the pleckstrin homology domain of PLC{gamma}1 in its interaction with the insulin receptor. JCB 163: 375-384 [Abstract] [Full Text]  
  • Skaletz-Rorowski, A., Lutchman, M., Kureishi, Y., Lefer, D. J., Faust, J. R., Walsh, K. (2003). HMG-CoA reductase inhibitors promote cholesterol-dependent Akt/PKB translocation to membrane domains in endothelial cells. Cardiovasc Res 57: 253-264 [Abstract] [Full Text]  
  • Liu, P., Rudick, M., Anderson, R. G. W. (2002). Multiple Functions of Caveolin-1. J. Biol. Chem. 277: 41295-41298 [Full Text]  
  • Nelson, B. A., Robinson, K. A., Buse, M. G. (2002). Insulin Acutely Regulates Munc18-c Subcellular Trafficking. ALTERED RESPONSE IN INSULIN-RESISTANT 3T3-L1 ADIPOCYTES. J. Biol. Chem. 277: 3809-3812 [Abstract] [Full Text]  
  • Bickel, P. E. (2002). Lipid rafts and insulin signaling. Am. J. Physiol. Endocrinol. Metab. 282: E1-E10 [Abstract] [Full Text]  
  • Razani, B., Combs, T. P., Wang, X. B., Frank, P. G., Park, D. S., Russell, R. G., Li, M., Tang, B., Jelicks, L. A., Scherer, P. E., Lisanti, M. P. (2002). Caveolin-1-deficient Mice Are Lean, Resistant to Diet-induced Obesity, and Show Hypertriglyceridemia with Adipocyte Abnormalities. J. Biol. Chem. 277: 8635-8647 [Abstract] [Full Text]  

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Müller, G.
Right arrow Articles by Frick, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Müller, G.
Right arrow Articles by Frick, W.